Chalcones and Carbon Dots as Emerging Breakthroughs in Glioblastoma Multiforme Treatment

Authors

  • Erika Travieso Gulliver Preparatory

DOI:

https://doi.org/10.47611/jsrhs.v12i1.4095

Keywords:

glioblastoma, chalcone, carbon dot, GSC, nanocarrier, drug delivery system

Abstract

Glioblastoma Multiforme (GBM) is a very aggressive brain tumor that is resistant to treatment and has a diverse population of genetically unstable, deeply infiltrating cells. Although significant efforts have been made to find new anti-GBM drugs, these efforts have largely been unsuccessful in human trials because of problems with effectiveness, selectivity, or physicochemical properties. The successful eradication of GBM stem cells (GSCs) is of high priority because GBM stem cells are in charge of patient relapse and tumor regrowth after therapy. The analysis of five published science journals has led to the conclusion that utilizing chalcones as the treatment for Glioblastoma and carbon dots as the carriers could change the approach to curing Glioblastoma. All of the authors examined have either conducted research with chalcones and carbon dots, or have reported their effectiveness from other published papers. The purpose of this paper will be to bring awareness to the potential of chalcones and carbon dots, seeing as they have been scarcely mentioned in the literature regarding Glioblastoma research.

Downloads

Download data is not yet available.

References or Bibliography

Glioblastoma: Current Status, Emerging Targets, and Recent Advances

Amandeep Thakur, Chetna Faujdar, Ram Sharma, Sachin Sharma, Basant Malik, Kunal Nepali, and Jing Ping Liou

Journal of Medicinal Chemistry 2022 65 (13), 8596-8685

DOI: 10.1021/acs.jmedchem.1c01946

Veliz, E.A.; Kaplina, A.; Hettiarachchi, S.D.; Yoham, A.L.; Matta, C.; Safar, S.; Sankaran, M.; Abadi, E.L.; Cilingir, E.K.; Vallejo, F.A.; et al. Chalcones as Anti-Glioblastoma Stem Cell Agent Alone or as Nanoparticle Formulation Using Carbon ``Dots as Nanocarrier. Pharmaceutics 2022, 14, 1465. https://doi.org/10.3390/ pharmaceutics14071465

Sansalone L, Veliz EA, Myrthil NG, Stathias V, Walters W, Torrens II, Schürer SC, Vanni S, Leblanc RM, Graham RM. Novel Curcumin Inspired Bis-Chalcone Promotes Endoplasmic Reticulum Stress and Glioblastoma Neurosphere Cell Death. Cancers (Basel). 2019 Mar 13;11(3):357. doi: 10.3390/cancers11030357. PMID: 30871215; PMCID: PMC6468769.

Mendanha D, Vieira de Castro J, Moreira J, Costa BM, Cidade H, Pinto M, Ferreira H, Neves NM. A New Chalcone Derivative with Promising Antiproliferative and Anti-Invasion Activities in Glioblastoma Cells. Molecules. 2021 Jun 3;26(11):3383. doi: 10.3390/molecules26113383. PMID: 34205043; PMCID: PMC8199914.

Calabrese G, De Luca G, Nocito G, Rizzo MG, Lombardo SP, Chisari G, Forte S, Sciuto EL, Conoci S. Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors. Int J Mol Sci. 2021 Oct 29;22(21):11783. doi: 10.3390/ijms222111783. PMID: 34769212; PMCID: PMC8583729.

Published

02-28-2023

How to Cite

Travieso, E. (2023). Chalcones and Carbon Dots as Emerging Breakthroughs in Glioblastoma Multiforme Treatment. Journal of Student Research, 12(1). https://doi.org/10.47611/jsrhs.v12i1.4095

Issue

Section

HS Review Projects